221 related articles for article (PubMed ID: 16504141)
1. Invasive fungal infections in neutropenic enterocolitis: a systematic analysis of pathogens, incidence, treatment and mortality in adult patients.
Gorschlüter M; Mey U; Strehl J; Schmitz V; Rabe C; Pauls K; Ziske C; Schmidt-Wolf IG; Glasmacher A
BMC Infect Dis; 2006 Feb; 6():35. PubMed ID: 16504141
[TBL] [Abstract][Full Text] [Related]
2. Neutropenic Enterocolitis in Critically Ill Patients: Spectrum of the Disease and Risk of Invasive Fungal Disease.
Duceau B; Picard M; Pirracchio R; Wanquet A; Pène F; Merceron S; Mokart D; Moreau AS; Lengliné E; Canet E; Lemiale V; Mariotte E; Azoulay E; Zafrani L
Crit Care Med; 2019 May; 47(5):668-676. PubMed ID: 30741755
[TBL] [Abstract][Full Text] [Related]
3. Neutropenic enterocolitis in adults: systematic analysis of evidence quality.
Gorschlüter M; Mey U; Strehl J; Ziske C; Schepke M; Schmidt-Wolf IG; Sauerbruch T; Glasmacher A
Eur J Haematol; 2005 Jul; 75(1):1-13. PubMed ID: 15946304
[TBL] [Abstract][Full Text] [Related]
4. Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial.
Cordonnier C; Pautas C; Maury S; Vekhoff A; Farhat H; Suarez F; Dhédin N; Isnard F; Ades L; Kuhnowski F; Foulet F; Kuentz M; Maison P; Bretagne S; Schwarzinger M
Clin Infect Dis; 2009 Apr; 48(8):1042-51. PubMed ID: 19281327
[TBL] [Abstract][Full Text] [Related]
5. Management of mycoses in surgical patients -- review of the literature.
Holzheimer RG; Dralle H
Eur J Med Res; 2002 May; 7(5):200-26. PubMed ID: 12069912
[TBL] [Abstract][Full Text] [Related]
6. Empiric treatment of fungal infections in the neutropenic host. Review of the literature and guidelines for use.
Sugar AM
Arch Intern Med; 1990 Nov; 150(11):2258-64. PubMed ID: 2241435
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic action of oral fluconazole against fungal infection in neutropenic patients. A meta-analysis of 16 randomized, controlled trials.
Kanda Y; Yamamoto R; Chizuka A; Hamaki T; Suguro M; Arai C; Matsuyama T; Takezako N; Miwa A; Kern W; Kami M; Akiyama H; Hirai H; Togawa A
Cancer; 2000 Oct; 89(7):1611-25. PubMed ID: 11013378
[TBL] [Abstract][Full Text] [Related]
8. Invasive fungal infections: epidemiology and analysis of antifungal prescriptions in onco-haematology.
des Champs-Bro B; Leroy-Cotteau A; Mazingue F; Pasquier F; François N; Corm S; Lemaitre L; Poulain D; Yakoub-Agha I; Alfandari S; Sendid B
J Clin Pharm Ther; 2011 Apr; 36(2):152-60. PubMed ID: 21366643
[TBL] [Abstract][Full Text] [Related]
9. Emerging moulds: epidemiological trends and antifungal resistance.
Miceli MH; Lee SA
Mycoses; 2011 Nov; 54(6):e666-78. PubMed ID: 21672045
[TBL] [Abstract][Full Text] [Related]
10. Wait and see or rush and switch? New questions for the management of patients with febrile neutropenia receiving antifungal prophylaxis.
Karthaus M; Hentrich M
Mycoses; 2011 Jan; 54 Suppl 1():1-6. PubMed ID: 21126265
[TBL] [Abstract][Full Text] [Related]
11. [Prophylaxis and treatment of invasive fungal infection in neutropenic patients].
Vallejo C; Rovira M
Rev Esp Quimioter; 2010 Dec; 23(4):177-83. PubMed ID: 21191555
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial prophylaxis and outpatient management of fever and neutropenia in adults treated for malignancy: American Society of Clinical Oncology clinical practice guideline.
Flowers CR; Seidenfeld J; Bow EJ; Karten C; Gleason C; Hawley DK; Kuderer NM; Langston AA; Marr KA; Rolston KV; Ramsey SD
J Clin Oncol; 2013 Feb; 31(6):794-810. PubMed ID: 23319691
[TBL] [Abstract][Full Text] [Related]
13. Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study.
Maertens J; Theunissen K; Verhoef G; Verschakelen J; Lagrou K; Verbeken E; Wilmer A; Verhaegen J; Boogaerts M; Van Eldere J
Clin Infect Dis; 2005 Nov; 41(9):1242-50. PubMed ID: 16206097
[TBL] [Abstract][Full Text] [Related]
14. Empirical antifungal treatment: a valid alternative for invasive fungal infection.
Vallejo C; Barberán J
Rev Esp Quimioter; 2011 Sep; 24(3):117-22. PubMed ID: 21947092
[TBL] [Abstract][Full Text] [Related]
15. Recent advances and challenges in the treatment of invasive fungal infections.
Shao PL; Huang LM; Hsueh PR
Int J Antimicrob Agents; 2007 Dec; 30(6):487-95. PubMed ID: 17961990
[TBL] [Abstract][Full Text] [Related]
16. Characterisation of breakthrough invasive mycoses in echinocandin recipients: an evidence-based review.
Sun HY; Singh N
Int J Antimicrob Agents; 2010 Mar; 35(3):211-8. PubMed ID: 20036518
[TBL] [Abstract][Full Text] [Related]
17. Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies: evidence from a meta-analysis of 3,597 patients.
Glasmacher A; Prentice A; Gorschlüter M; Engelhart S; Hahn C; Djulbegovic B; Schmidt-Wolf IG
J Clin Oncol; 2003 Dec; 21(24):4615-26. PubMed ID: 14673051
[TBL] [Abstract][Full Text] [Related]
18. Increasing fungal infections in the intensive care unit.
De Pauw BE
Surg Infect (Larchmt); 2006; 7 Suppl 2():S93-6. PubMed ID: 16895517
[TBL] [Abstract][Full Text] [Related]
19. The incidence of invasive fungal infections in neutropenic patients with acute leukemia and myelodysplastic syndromes receiving primary antifungal prophylaxis with voriconazole.
Barreto JN; Beach CL; Wolf RC; Merten JA; Tosh PK; Wilson JW; Hogan WJ; Litzow MR
Am J Hematol; 2013 Apr; 88(4):283-8. PubMed ID: 23460251
[TBL] [Abstract][Full Text] [Related]
20. Updated guidelines for managing fungal diseases in hematology patients.
Hicheri Y; Toma A; Maury S; Pautas C; Mallek-Kaci H; Cordonnier C
Expert Rev Anti Infect Ther; 2010 Sep; 8(9):1049-60. PubMed ID: 20818948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]